EYS p.Val1362=
c.4086C>A · rs1766419897 · VCV1648663
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
|---|---|---|
| Constraint at this position | ||
| Conservation | phyloP 1.3 | phastCons 0.002 |
| Overall | ||
| CADD | 0.847 | PHRED · no single calibrated threshold — expert panels disagree |
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Admixed Americangrpmax | 0.00589% | 16,991 |
| Remaining individualsnot grpmax-eligible | 0.00333% | 30,052 |
| European (non-Finnish) | 0.000698% | 143,340 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- EYS
- Protein
- p.Val1362=
- Coding
- c.4086C>A
- MANE Select
- NM_001142800
- dbSNP
- rs1766419897
- Type
- single nucleotide variant
- Location
- chr6:64591781 (GRCh38)
- Gene constraint
- LOEUF 0.96 · pLI <0.01 (gnomAD)
Disease context
retinitis pigmentosa 25 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Retinitis pigmentosa (Orphanet):
- Inheritance
- Autosomal dominant, Autosomal recessive, Mitochondrial inheritance
- Onset
- Adolescent, Adult, Childhood
- Prevalence
- 1-5 / 10 000 (Europe)
Similar variants
- EYS c.1056+1G>A Pathogenic/Likely pathogenic ★★ same condition
- EYS c.1056+3A>C Likely pathogenic ★★ same condition
- EYS c.1057-1G>A Likely pathogenic ★★ same condition
- EYS c.1184+1G>A Pathogenic/Likely pathogenic ★★ same condition
- EYS c.1184+1G>T Likely pathogenic ★★ same condition
- EYS c.1185-1G>A Likely pathogenic ★★ same condition
- EYS c.1299+2T>A Likely pathogenic ★★ same condition
- EYS c.1599+1G>T Likely pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/eys-p-val1362 (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown